Literature DB >> 24079951

Pooling ocular swab specimens from Tanzania for testing by Roche Amplicor and Aptima Combo 2 assays for the detection of Chlamydia trachomatis: accuracy and cost-savings.

Laura Dize1, Sheila West, Thomas C Quinn, Charlotte A Gaydos.   

Abstract

Ocular swabs collected in Tanzania were evaluated by Amplicor CT PCR and Aptima Combo2 assays for the detection of Chlamydia trachomatis to determine if pooling could be used to reduce the cost of detection. Pooling would be an accurate method and has thus far resulted in a cost-savings of 62.2%.
© 2013.

Entities:  

Keywords:  Chlamydia trachomatis; Cost-savings; Pooling; Trachoma

Mesh：

Substances：

Year:  2013        PMID： 24079951      PMCID： PMC4160034          DOI： 10.1016/j.diagmicrobio.2013.08.005

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  12 in total

1.  Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.

Authors:  Dianne Stare; Emma Harding-Esch; Beatriz Munoz; Robin Bailey; David Mabey; Martin Holland; Charlotte Gaydos; Sheila West
Journal:  Ophthalmic Epidemiol       Date:  2011-02       Impact factor: 1.648

2.  Performance of the MagNA pure LC robot for extraction of Chlamydia trachomatis and Neisseria gonorrhoeae DNA from urine and swab specimens.

Authors:  Nicholas Dalesio; Vince Marsiglia; Andrew Quinn; Thomas C Quinn; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

3.  Cost-effectiveness of trachoma control in seven world regions.

Authors:  Rob M P M Baltussen; Mariame Sylla; Kevin D Frick; Silvio P Mariotti
Journal:  Ophthalmic Epidemiol       Date:  2005-04       Impact factor: 1.648

4.  Comparison of the Abbott m2000 RealTime CT assay and the Cepheid GeneXpert CT/NG assay to the Roche Amplicor CT assay for detection of Chlamydia trachomatis in ocular samples from Tanzania.

Authors:  Laura Dize; Sheila West; James A Williams; Barbara Van Der Pol; Thomas C Quinn; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

5.  Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection.

Authors:  J Diamant; R Benis; J Schachter; J Moncada; F Pang; H C Jha; R C Bhatta; T Porco; T Lietman
Journal:  Ophthalmic Epidemiol       Date:  2001-07       Impact factor: 1.648

6.  Cost savings and increased efficiency using a stratified specimen pooling strategy for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Joanna Lynn Lewis; Vivian Marie Lockary; Sadika Kobic
Journal:  Sex Transm Dis       Date:  2012-01       Impact factor: 2.830

7.  How reliable are tests for trachoma?--a latent class approach.

Authors:  Craig W See; Wondu Alemayehu; Muluken Melese; Zhaoxia Zhou; Travis C Porco; Stephen Shiboski; Bruce D Gaynor; John Eng; Jeremy D Keenan; Thomas M Lietman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-03       Impact factor: 4.799

8.  Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.

Authors:  Jaya D Chidambaram; Wondu Alemayehu; Muluken Melese; Takele Lakew; Elizabeth Yi; Jenafir House; Vicky Cevallos; Zhaoxia Zhou; Kathryn Maxey; David C Lee; Brett L Shapiro; Muthiah Srinivasan; Travis Porco; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

9.  Pooling samples: the key to sensitive, specific and cost-effective genetic diagnosis of Chlamydia trachomatis in low-resource countries.

Authors:  Elena Shipitsyna; Kira Shalepo; Alevtina Savicheva; Magnus Unemo; Marius Domeika
Journal:  Acta Derm Venereol       Date:  2007       Impact factor: 4.437

Review 10.  The global burden of trachoma: a review.

Authors:  Matthew J Burton; David C W Mabey
Journal:  PLoS Negl Trop Dis       Date:  2009-10-27
View more
  13 in total

Review 1.  Ocular Chlamydia trachomatis infection: elimination with mass drug administration.

Authors:  Meraf A Wolle; Sheila K West
Journal:  Expert Rev Anti Infect Ther       Date:  2019-02-18       Impact factor: 5.091

2.  Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay.

Authors:  L Dize; S K West; H Mkocha; T C Quinn; C A Gaydos
Journal:  Diagn Microbiol Infect Dis       Date:  2014-11-27       Impact factor: 2.803

3.  Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.

Authors:  Ann-Margret Ervin; Harran Mkocha; Beatriz Munoz; Kurt Dreger; Laura Dize; Charlotte Gaydos; Thomas C Quinn; Sheila K West
Journal:  Ophthalmic Epidemiol       Date:  2016-11-07       Impact factor: 1.648

4.  Serology for trachoma surveillance after cessation of mass drug administration.

Authors:  Diana L Martin; Rhiannon Bid; Frank Sandi; E Brook Goodhew; Patrick A Massae; Augustin Lasway; Heiko Philippin; William Makupa; Sandra Molina; Martin J Holland; David C W Mabey; Chris Drakeley; Patrick J Lammie; Anthony W Solomon
Journal:  PLoS Negl Trop Dis       Date:  2015-02-25

5.  Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.

Authors:  Emma Harding-Esch; Mireia Jofre-Bonet; Jaskiran K Dhanjal; Sarah Burr; Tansy Edwards; Martin Holland; Ansumana Sillah; Sheila West; Tom Lietman; Jeremy Keenan; David Mabey; Robin Bailey
Journal:  PLoS Negl Trop Dis       Date:  2015-04-22

6.  Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration.

Authors:  Erica Brook Goodhew; Sheri Maria G Morgan; Andrew J Switzer; Beatriz Munoz; Laura Dize; Charlotte Gaydos; Harran Mkocha; Sheila K West; Ryan E Wiegand; Patrick J Lammie; Diana L Martin
Journal:  BMC Infect Dis       Date:  2014-04-22       Impact factor: 3.090

7.  Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies.

Authors:  Stephanie J Migchelsen; Diana L Martin; Khamphoua Southisombath; Patrick Turyaguma; Anne Heggen; Peter Paul Rubangakene; Hassan Joof; Pateh Makalo; Gretchen Cooley; Sarah Gwyn; Anthony W Solomon; Martin J Holland; Paul Courtright; Rebecca Willis; Neal D E Alexander; David C W Mabey; Chrissy H Roberts
Journal:  PLoS Negl Trop Dis       Date:  2017-01-18

8.  Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial.

Authors:  Sheila K West; Beatriz Munoz; Harran Mkocha; Laura Dize; Charlotte A Gaydos; Bonnie Swenor; Ann-Margret Ervin; Thomas C Quinn
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

9.  Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem.

Authors:  Laura G Senyonjo; Oscar Debrah; Diana L Martin; Adwoa Asante-Poku; Stephanie J Migchelsen; Sarah Gwyn; Dzeidzom K deSouza; Anthony W Solomon; David Agyemang; Nana Biritwum-Kwadwo; Benjamin Marfo; Didier Bakajika; Ernest O Mensah; Agatha Aboe; Joseph Koroma; James Addy; Robin Bailey
Journal:  PLoS Negl Trop Dis       Date:  2018-12-14

10.  Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area.

Authors:  Sheila K West; Beatriz Munoz; Hemjot Kaur; Laura Dize; Harran Mkocha; Charlotte A Gaydos; Thomas C Quinn
Journal:  Sci Rep       Date:  2018-02-23       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.